H (continued)
- hexamethylmelamine
- Hexvix
- HexvixR
- hexyl 5-aminolevulinate
- HibTITER
- HIF-1alpha inhibitor PX-478
- high-selenium baker's yeast
- high-selenium Brassica juncea
- Hiltonol
- Hivid
- HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine
- HLA-A*0201-restricted URLC10-VEGFR1-VEGFR2 multipeptide vaccine
- HLA-A*0201-restricted VEGFR1 peptide vaccine
- HLA-A*0201-restricted VEGFR1-VEGFR2 multipeptide vaccine
- HLA-A*2402-restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 multipeptide vaccine
- HLA-A*2402-restricted URLC10 peptides vaccine
- HLA-A*2402-restricted URLC10-CDCA1-VEGFR1-VEGFR2 multipeptide vaccine
- HLA-A*2402-restricted URLC10-KOC1-VEGFR1-VEGFR2 multipeptide vaccine
- HLA-A*2402-restricted URLC10-TTK-KOC1 multipeptide vaccine
- HLA-A*2402-restricted URLC10-TTK-VEGFR1-VEGFR2 multipeptide vaccine
- HLA-A*2402-restricted VEGFR1 peptide vaccine
- HLA-A*2404-restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine
- HLA-A1, A2, B35-restricted survivin peptides / Montanide ISA-51 vaccine
- HLA-A2, A3-restricted FGF-5 peptides / Montanide ISA-51 vaccine
- HLA-A2-restricted synthetic glioma antigen peptides vaccine
H (continued)
- Hodgkin's antigens-GM-CSF-expressing cell vaccine
- host dendritic cell vaccine-001 MSSM / BIIR
- HPPH
- HPV 16 E7:86-93 peptide vaccine
- HPV DNA plasmids therapeutic vaccine VGX-3100
- HPV L1 VLP vaccine V504
- Hsp27 antisense oligonucleotide OGX-427
- Hsp90 antagonist KW-2478
- Hsp90 inhibitor AB-010
- Hsp90 inhibitor AT13387
- Hsp90 inhibitor AUY922
- Hsp90 inhibitor BIIB028
- Hsp90 inhibitor CNF2024
- HSP90 inhibitor HSP990
- Hsp90 inhibitor MPC-3100
- Hsp90 inhibitor SNX-5422 mesylate
- Hsp90 inhibitor STA-9090
- Hsp90 inhibitor XL888
- HspE7
- HSV-1 HF10
- HSV-TK-transduced donor lymphocytes
- hTERT / survivin / melanoma tumor cell-derived mRNA-transfected dendritic cell vaccine
- hTERT I540 / R572Y / D988Y multipeptide vaccine
- hTERT vaccine V934 / V935
- hu14.18-IL2 fusion protein